Pacific signs exclusive agreement with Shire over mesalazine

Published: 2009-03-05 06:56:00

Updated: 2009-03-05 06:56:00

Pacific Pharm announced on March 2 that it entered into an exclusive agreement with Shire Pharmaceutical Ireland Ltd. to locally distribute a novel dosage form of mesalazine using a drug delivery system.

Its launching is expected to help expand Pacific’s presence in the domestic digestive sect...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK